Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CLDX

Celldex Therapeutics, Inc.

CIK 0000744218 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$40.38
↑ 0.44 (1.10%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap
$3.17B
P/E Ratio
-10.55
EPS
-3.90
Dividend Yield
Not covered
52W Position
81%
Beta
1.29

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
4.44
P/S
Not covered
EV/Revenue
Not covered
ROE
-42.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 81%
$20.37$45.14

Latest Financials

2025-12-31 FY
Revenue
$1.54M
Net Income
-$258.76M
Total Assets
$582.98M
Free Cash Flow
-$213.66M

Recent news